Discovery Labs developing former GSK facility into $500M healthcare, life sciences tech community

The Discovery Labs, which was formed by MLP Ventures, is developing a $500 million healthcare, life sciences and tech co-working community at the former GlaxoSmithKline facility in King of Prussia, Pennsylvania. (Discovery Labs)

The Discovery Labs, which was formed by MLP Ventures, is developing a $500 million healthcare, life sciences and tech co-working community at the former GlaxoSmithKline facility in King of Prussia, Pennsylvania.

When completed, the campus will feature a 1.6 million-square-foot collaborative laboratory as well as the 640,000-square-foot Innovation at Renaissance Campus. The idea is to turn the site into the world’s largest co-working “ecosystem” for healthcare, life sciences and tech-enabled companies.

GSK continues to operate a sterile injectables manufacturing plant on its East Campus in Upper Merion, Pennsylvania.

Free Amazon Webinar

Performing end to end real-world evidence generation in the cloud with traceability and transparency- a Sanofi journey

In this webinar you will hear about Sanofi’s journey and experience in building an industrialized big data & analytics platform in the cloud that handles billions of rows of RWD data with complete data traceability, security, and supports both traditional and advanced analytics for day to day evidence generation (RWE).

“The size of each Discovery Labs enables enterprise level companies to work side by side with startup and emerging companies and enjoy the benefits of the co-working phenomenon,” Audrey Greenberg, Discovery Labs' chief executive, said in a statement. “It is the first of a network of massive co-working properties which will encourage powerful, collaborative innovation on an international scale.”

GSK sold the site last year for a reported $77 million to O’Neill Properties, which later became MLP Ventures.

A major attraction at the campus will be a 100-square-foot incubator operated by the Pennsylvania Biotech Center that will be dubbed IQ Connect. The space will be designed to attract millennial workers by offering on-site coffee shops and restaurants, a $10 million conference center with a 275-seat auditorium and a fitness center that will offer yoga and Pilates classes. They also plan to include walking trails and an outdoor amphitheater.

Suggested Articles

Nearly four decades after it was approved, the FDA has ordered that heartburn drug Zantac and its generics be removed from the market.

Pfizer's 1.1-million-square-foot sterile injectables plant in Visakhapatnam has been criticized by the FDA for poor quality testing.

Amidst a gung-ho shift to oncology, Daiichi is also fleshing out its gene therapy capacity with a $200 million licensing deal with Ultragenyx.